Free Trial

Westlake (WLK) Financials

Westlake logo
$98.28 +4.43 (+4.71%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Westlake

Annual Income Statements for Westlake

This table shows Westlake's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
646 399 1,304 996 421 330 2,015 2,247 479 602 -1,508
Consolidated Net Income / (Loss)
665 420 1,339 1,034 462 373 2,070 2,297 522 647 -1,471
Net Income / (Loss) Continuing Operations
665 420 1,339 1,034 462 373 2,070 2,297 522 647 -1,471
Total Pre-Tax Income
963 558 1,081 1,334 570 331 2,677 2,946 700 938 -1,597
Total Operating Income
960 583 1,225 1,408 656 429 2,800 3,050 729 875 -1,578
Total Gross Profit
1,185 983 1,761 1,987 1,260 1,023 3,495 4,073 2,219 1,957 813
Total Revenue
4,463 5,076 8,041 8,635 8,118 7,504 11,778 15,794 12,548 12,142 11,170
Operating Revenue
4,463 5,076 8,041 8,635 8,118 7,504 11,778 15,794 12,548 12,142 11,170
Total Cost of Revenue
3,278 4,093 6,280 6,648 6,858 6,481 8,283 11,721 10,329 10,185 10,357
Operating Cost of Revenue
3,278 4,093 6,280 6,648 6,858 6,481 8,283 11,721 10,329 10,185 10,357
Total Operating Expenses
225 400 536 579 604 594 695 1,023 1,490 1,082 2,391
Selling, General & Admin Expense
218 258 399 445 458 449 551 835 865 874 900
Amortization Expense
7.00 38 108 101 109 109 123 155 122 117 124
Impairment Charge
- - - - - - 0.00 0.00 475 0.00 727
Restructuring Charge
0.00 104 29 33 37 36 21 33 28 91 640
Total Other Income / (Expense), net
3.00 -25 -144 -74 -86 -98 -123 -104 -29 63 -19
Interest Expense
35 79 159 126 124 142 176 177 165 159 171
Other Income / (Expense), net
38 54 15 52 38 44 53 73 136 222 152
Income Tax Expense
298 138 -258 300 108 -42 607 649 178 291 -126
Net Income / (Loss) Attributable to Noncontrolling Interest
19 21 35 38 41 43 55 50 43 45 37
Basic Earnings per Share
$4.88 $3.07 $10.05 $7.66 $3.26 $2.57 $15.66 $17.46 $3.73 $4.66 ($11.70)
Weighted Average Basic Shares Outstanding
131.82M 129.37M 129.09M 129.40M 128.40M 127.85M 128.00M 127.97M 127.81M 128.54M 128.26M
Diluted Earnings per Share
$4.86 $3.06 $10.00 $7.62 $3.25 $2.56 $15.58 $17.34 $3.70 $4.64 ($11.70)
Weighted Average Diluted Shares Outstanding
132.30M 129.97M 129.54M 129.99M 128.76M 128.09M 128.70M 128.85M 128.60M 129.21M 128.26M
Weighted Average Basic & Diluted Shares Outstanding
132.40M 130M 129.80M 130M 128.39M 127.83M 127.92M 127.36M 128.22M 128.23M 127.91M
Cash Dividends to Common per Share
$0.69 $0.74 $0.80 $0.92 $1.03 $1.07 $1.14 $1.31 $1.71 $2.05 $2.11

Quarterly Income Statements for Westlake

This table shows Westlake's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
285 -497 174 313 108 7.00 -40 -142 -782 -544 -169
Consolidated Net Income / (Loss)
295 -487 185 323 120 19 -35 -131 -772 -533 -157
Net Income / (Loss) Continuing Operations
295 -487 185 323 120 19 -35 -131 -772 -533 -157
Total Pre-Tax Income
365 -558 233 424 185 96 -34 -125 -775 -663 -190
Total Operating Income
349 -552 223 406 180 66 -32 -109 -766 -671 -172
Total Gross Profit
586 199 466 664 499 328 232 258 236 87 112
Total Revenue
3,115 2,826 2,975 3,207 3,117 2,843 2,846 2,953 2,838 2,533 2,652
Operating Revenue
3,115 2,826 2,975 3,207 3,117 2,843 2,846 2,953 2,838 2,533 2,652
Total Cost of Revenue
2,529 2,627 2,509 2,543 2,618 2,515 2,614 2,695 2,602 2,446 2,540
Operating Cost of Revenue
2,529 2,627 2,509 2,543 2,618 2,515 2,614 2,695 2,602 2,446 2,540
Total Operating Expenses
237 751 243 258 319 262 264 367 1,002 758 284
Selling, General & Admin Expense
206 224 209 224 215 226 227 221 228 224 236
Amortization Expense
31 30 30 30 29 28 30 31 30 33 30
Restructuring Charge
0.00 22 4.00 4.00 75 8.00 7.00 115 17 501 18
Total Other Income / (Expense), net
16 -6.00 10 18 5.00 30 -2.00 -16 -9.00 8.00 -18
Interest Expense
40 41 40 41 39 39 39 40 41 51 56
Other Income / (Expense), net
56 35 50 59 44 69 37 24 32 59 38
Income Tax Expense
70 -71 48 101 65 77 1.00 6.00 -3.00 -130 -33
Net Income / (Loss) Attributable to Noncontrolling Interest
10 10 11 10 12 12 5.00 11 10 11 12
Basic Earnings per Share
$2.22 ($3.88) $1.35 $2.42 $0.84 $0.05 ($0.31) ($1.11) ($6.06) ($4.22) ($1.31)
Weighted Average Basic Shares Outstanding
127.85M 127.81M 128.36M 128.58M 128.64M 128.54M 128.31M 128.24M 128.25M 128.26M 127.99M
Diluted Earnings per Share
$2.20 ($3.86) $1.34 $2.40 $0.83 $0.07 ($0.31) ($1.11) ($6.06) ($4.22) ($1.31)
Weighted Average Diluted Shares Outstanding
128.58M 128.60M 129.02M 129.35M 129.34M 129.21M 128.31M 128.24M 128.25M 128.26M 127.99M
Weighted Average Basic & Diluted Shares Outstanding
128.14M 128.22M 128.57M 128.59M 128.71M 128.23M 128.24M 128.25M 128.27M 127.91M 128.12M
Cash Dividends to Common per Share
$0.50 - $0.50 $0.50 $0.53 - $0.53 $0.53 $0.53 - $0.53

Annual Cash Flow Statements for Westlake

This table details how cash moves in and out of Westlake's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-218 -17 908 -779 -25 587 604 305 1,073 -384 -195
Net Cash From Operating Activities
1,079 867 1,528 1,409 1,301 1,297 2,394 3,395 2,336 1,314 465
Net Cash From Continuing Operating Activities
1,079 867 1,528 1,409 1,301 1,297 2,394 3,395 2,336 1,314 465
Net Income / (Loss) Continuing Operations
665 420 1,339 1,034 462 373 2,070 2,297 522 647 -1,471
Consolidated Net Income / (Loss)
665 420 1,339 1,034 462 373 2,070 2,297 522 647 -1,471
Depreciation Expense
246 378 601 641 713 773 840 1,056 1,097 1,114 1,178
Non-Cash Adjustments To Reconcile Net Income
-4.00 -31 45 66 74 62 59 82 563 84 1,127
Changes in Operating Assets and Liabilities, net
172 100 -457 -332 52 89 -575 -40 154 -531 -369
Net Cash From Investing Activities
-1,006 -2,563 -652 -754 -1,954 -509 -3,213 -2,479 -1,037 -1,001 -1,223
Net Cash From Continuing Investing Activities
-1,006 -2,563 -652 -754 -1,954 -509 -3,213 -2,479 -1,037 -1,001 -1,223
Purchase of Property, Plant & Equipment
-491 -629 -577 -702 -787 -525 -658 -1,108 -1,034 -1,008 -995
Acquisitions
- -2,438 -13 0.00 -314 -18 -2,554 -1,203 -25 -26 -33
Purchase of Investments
-605 -138 - - - - - - 0.00 0.00 -272
Sale and/or Maturity of Investments
49 663 - 0.00 0.00 44 - - 0.00 0.00 68
Other Investing Activities, net
-3.00 -21 -62 -52 -853 -10 -1.00 -168 22 33 9.00
Net Cash From Financing Activities
-287 1,687 6.00 -1,427 630 -216 1,437 -587 -245 -650 530
Net Cash From Continuing Financing Activities
-287 1,687 6.00 -1,427 630 -216 1,437 -587 -245 -650 530
Repayment of Debt
-74 -174 -957 -1,165 -5.00 -1,269 -24 -250 53 -277 -271
Repurchase of Common Equity
-163 -67 0.00 -106 -30 -54 -30 -101 -23 -60 -63
Payment of Dividends
-107 -114 -131 -165 -182 -192 -193 -229 -275 -313 -323
Issuance of Debt
57 2,042 983 9.00 784 1,299 1,671 -25 0.00 0.00 1,187
Effect of Exchange Rate Changes
-4.00 - - - -2.00 15 -14 - 19 -47 33

Quarterly Cash Flow Statements for Westlake

This table details how cash moves in and out of Westlake's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
380 247 -195 -66 -127 4.00 -622 -213 -157 797 -452
Net Cash From Operating Activities
696 573 169 237 474 434 -77 135 182 225 -94
Net Cash From Continuing Operating Activities
696 573 169 237 474 434 -77 135 182 225 -94
Net Income / (Loss) Continuing Operations
295 -487 185 323 120 19 -35 -131 -772 -533 -157
Consolidated Net Income / (Loss)
295 -487 185 323 120 19 -35 -131 -772 -533 -157
Depreciation Expense
277 282 273 279 281 281 283 295 303 297 284
Non-Cash Adjustments To Reconcile Net Income
22 508 14 19 29 22 12 23 752 340 13
Changes in Operating Assets and Liabilities, net
102 270 -303 -384 44 112 -337 -52 -101 121 -234
Net Cash From Investing Activities
-251 -287 -272 -223 -241 -265 -434 -292 -242 -255 -271
Net Cash From Continuing Investing Activities
-251 -287 -272 -223 -241 -265 -434 -292 -242 -255 -271
Purchase of Property, Plant & Equipment
-245 -282 -272 -231 -220 -285 -248 -267 -239 -241 -209
Acquisitions
- - -1.00 - - - 0.00 -16 -1.00 -10 -62
Purchase of Investments
-16 - 0.00 - - - -189 -9.00 -6.00 -74 -35
Sale and/or Maturity of Investments
- - - - - - 0.00 - - - 33
Other Investing Activities, net
10 -23 1.00 8.00 2.00 -4.00 3.00 - 4.00 2.00 2.00
Net Cash From Financing Activities
-44 -70 -74 -72 -371 -133 -115 -82 -88 815 -82
Net Cash From Continuing Financing Activities
-44 -70 -74 -72 -371 -133 -115 -82 -88 815 -82
Repurchase of Common Equity
- - 0.00 - - -60 -30 - - -33 0.00
Payment of Dividends
-73 -86 -75 -76 -77 -85 -78 -81 -78 -86 -78
Issuance of Debt
- 11 - - - 12 - - - - -4.00
Other Net Changes in Cash
- - - - - - - - - - -5.00

Annual Balance Sheets for Westlake

This table presents Westlake's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,569 10,890 12,076 11,602 13,261 13,835 18,459 20,550 21,035 20,750 19,961
Total Current Assets
2,175 2,408 3,463 2,842 2,742 3,477 5,263 5,973 6,609 6,214 6,216
Cash & Equivalents
663 459 1,531 753 728 1,313 1,908 2,228 3,304 2,919 2,724
Short-Term Investments
520 - - - - - - - - 0.00 204
Accounts Receivable
509 939 1,001 1,037 1,036 1,214 1,868 1,801 1,601 1,483 1,504
Inventories, net
434 801 900 1,014 936 918 1,407 1,866 1,622 1,697 1,653
Prepaid Expenses
14 48 31 38 42 32 80 78 82 115 131
Plant, Property, & Equipment, net
3,004 6,420 6,412 6,595 6,912 6,920 7,606 8,477 8,519 8,633 8,605
Total Noncurrent Assets
390 2,062 2,201 2,165 3,084 3,438 5,590 6,100 5,907 5,903 5,140
Long-Term Investments
- - - 253 1,112 1,059 1,007 1,142 1,115 1,081 1,062
Goodwill
62 947 1,012 1,002 1,074 1,083 2,024 2,161 2,041 2,031 1,314
Intangible Assets
151 787 777 134 187 612 1,580 1,565 1,403 1,282 1,182
Other Noncurrent Operating Assets
177 328 412 776 711 684 979 1,232 1,348 1,509 1,582
Total Liabilities & Shareholders' Equity
5,569 10,890 12,076 11,602 13,261 13,835 18,459 20,550 21,035 20,750 19,961
Total Liabilities
2,007 6,998 6,707 5,526 6,858 7,257 9,931 10,085 10,271 9,707 10,666
Total Current Liabilities
523 1,183 1,967 1,183 1,241 1,357 2,344 2,298 2,790 2,219 2,770
Short-Term Debt
0.00 149 710 - - 0.00 269 0.00 299 6.00 497
Accounts Payable
235 496 600 507 473 536 879 889 877 851 783
Accrued Expenses
287 538 657 676 768 821 1,196 1,409 1,614 1,362 1,490
Total Noncurrent Liabilities
1,485 5,815 4,740 4,343 5,617 5,900 7,587 7,787 7,481 7,488 7,896
Long-Term Debt
758 3,679 3,127 2,668 3,445 3,566 4,911 4,879 4,607 4,556 5,087
Noncurrent Deferred & Payable Income Tax Liabilities
576 1,650 1,111 1,159 1,255 1,368 1,681 1,735 1,560 1,553 1,343
Noncurrent Employee Benefit Liabilities
123 365 344 337 360 391 291 355 363 304 286
Other Noncurrent Operating Liabilities
28 121 158 179 557 575 704 818 951 1,075 1,180
Commitments & Contingencies
0.00 - - - - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,562 3,892 5,369 6,076 6,403 6,578 8,528 10,465 10,764 11,043 9,295
Total Preferred & Common Equity
3,266 3,524 4,874 5,590 5,860 6,043 7,955 9,931 10,241 10,527 8,792
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,266 3,524 4,874 5,590 5,860 6,043 7,955 9,931 10,241 10,527 8,792
Common Stock
543 552 556 557 554 570 582 602 631 657 684
Retained Earnings
3,110 3,412 4,613 5,477 5,757 5,938 7,808 9,885 10,143 10,481 8,701
Treasury Stock
-258 -319 -302 -382 -377 -401 -399 -467 -435 -467 -513
Accumulated Other Comprehensive Income / (Loss)
-129 -121 7.00 -62 -74 -64 -36 -89 -98 -144 -80
Noncontrolling Interest
296 368 495 486 543 535 573 534 523 516 503

Quarterly Balance Sheets for Westlake

This table presents Westlake's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
20,806 20,981 21,396 20,960 21,083 21,109 20,711 20,806 19,814 19,707
Total Current Assets
6,146 6,296 6,757 6,526 6,609 6,549 6,021 5,946 5,751 5,952
Cash & Equivalents
2,414 2,677 3,057 3,108 3,042 2,915 2,297 2,085 1,927 2,271
Short-Term Investments
- - - - - - 183 192 198 205
Accounts Receivable
1,835 1,855 1,939 1,691 1,812 1,754 1,656 1,832 1,763 1,690
Inventories, net
1,842 1,671 1,672 1,661 1,684 1,747 1,781 1,731 1,727 1,677
Prepaid Expenses
55 93 89 66 71 133 104 106 136 109
Plant, Property, & Equipment, net
8,518 8,550 8,570 8,523 8,541 8,602 8,674 8,827 8,825 8,579
Total Noncurrent Assets
6,142 6,135 6,069 5,911 5,933 5,958 6,016 6,033 5,238 5,176
Long-Term Investments
1,131 1,120 1,117 1,104 1,085 1,099 1,075 1,074 1,063 1,049
Goodwill
2,167 2,167 2,161 2,037 2,035 2,039 2,032 2,044 1,314 1,345
Intangible Assets
1,539 1,507 1,471 1,370 1,338 1,312 1,259 1,239 1,208 1,215
Other Noncurrent Operating Assets
1,305 1,341 1,320 1,400 1,475 1,508 1,650 1,676 1,653 1,567
Total Liabilities & Shareholders' Equity
20,806 20,981 21,396 20,960 21,083 21,109 20,711 20,806 19,814 19,707
Total Liabilities
9,978 9,904 10,111 10,107 9,989 9,923 9,790 10,015 9,876 10,656
Total Current Liabilities
2,159 2,131 2,659 2,655 2,537 2,351 2,285 2,403 2,897 2,743
Short-Term Debt
- - 299 300 300 0.00 - - 750 496
Accounts Payable
828 802 811 891 885 898 955 926 799 811
Accrued Expenses
1,331 1,329 1,549 1,464 1,352 1,453 1,330 1,477 1,348 1,436
Total Noncurrent Liabilities
7,819 7,773 7,452 7,452 7,452 7,572 7,505 7,612 6,979 7,913
Long-Term Debt
4,892 4,894 4,574 4,590 4,585 4,616 4,588 4,654 3,906 5,074
Noncurrent Deferred & Payable Income Tax Liabilities
1,716 1,692 1,680 1,544 1,515 1,514 1,546 1,524 1,578 1,388
Noncurrent Employee Benefit Liabilities
357 358 349 353 348 356 309 325 323 279
Other Noncurrent Operating Liabilities
854 829 849 965 1,004 1,086 1,062 1,109 1,172 1,172
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
10,828 11,077 11,285 10,853 11,094 11,186 10,921 10,791 9,938 9,051
Total Preferred & Common Equity
10,291 10,544 10,754 10,331 10,574 10,662 10,410 10,278 9,426 8,547
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
10,291 10,544 10,754 10,331 10,574 10,662 10,410 10,278 9,426 8,547
Common Stock
591 602 620 625 636 646 651 663 674 686
Retained Earnings
10,232 10,484 10,705 10,252 10,500 10,541 10,373 10,163 9,313 8,464
Treasury Stock
-465 -463 -440 -414 -413 -408 -484 -484 -484 -504
Accumulated Other Comprehensive Income / (Loss)
-67 -79 -131 -132 -149 -117 -130 -64 -77 -99
Noncontrolling Interest
537 533 531 522 520 524 511 513 512 504

Annual Metrics And Ratios for Westlake

This table displays calculated financial ratios and metrics derived from Westlake's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.08% 13.74% 58.41% 7.39% -5.99% -7.56% 56.96% 34.10% -20.55% -3.24% -8.01%
EBITDA Growth
-6.57% -18.41% 81.38% 14.12% -33.03% -11.44% 196.39% 13.16% -53.05% 12.69% -111.22%
EBIT Growth
-10.99% -36.17% 94.66% 17.74% -52.47% -31.84% 503.17% 9.46% -72.30% 26.82% -229.99%
NOPAT Growth
-6.67% -33.81% 245.79% -28.08% -51.28% -9.08% 347.86% 9.84% -77.14% 11.02% -283.02%
Net Income Growth
-2.92% -36.84% 218.81% -22.78% -55.32% -19.26% 454.96% 10.97% -77.27% 23.95% -327.36%
EPS Growth
-4.14% -37.04% 226.80% -23.80% -57.35% -21.23% 508.59% 11.30% -78.66% 25.41% -352.16%
Operating Cash Flow Growth
4.52% -19.65% 76.24% -7.79% -7.67% -0.31% 84.58% 41.81% -31.19% -43.75% -64.61%
Free Cash Flow Firm Growth
442.55% -741.27% 126.74% 9.12% -23.69% -74.97% -535.71% 239.86% 5.81% -80.30% -255.72%
Invested Capital Growth
3.75% 126.30% 8.10% 0.82% -3.27% 3.83% 38.87% 10.94% -6.04% 3.15% -6.17%
Revenue Q/Q Growth
-3.24% 17.32% 3.53% -0.17% -1.36% 1.10% 15.06% 0.00% -3.63% 0.14% -2.70%
EBITDA Q/Q Growth
-7.85% 5.80% 12.88% -6.37% -5.25% 7.79% 25.27% 0.00% -30.33% 41.73% -151.35%
EBIT Q/Q Growth
-9.90% -4.41% 20.26% -9.82% -12.37% 20.97% 32.57% 0.00% -50.00% 146.52% -110.01%
NOPAT Q/Q Growth
-10.74% 3.74% 106.73% -39.80% -7.44% 1.38% 33.47% 0.00% -57.96% 373.02% -87.63%
Net Income Q/Q Growth
-9.68% -2.48% 113.07% -39.85% -9.06% 11.34% 35.12% 0.00% -58.47% 358.87% -60.07%
EPS Q/Q Growth
-10.99% -4.08% 117.39% -40.61% -10.71% 13.78% 35.83% 0.00% -60.51% 553.52% -57.89%
Operating Cash Flow Q/Q Growth
-1.69% 10.89% 18.93% -18.13% 6.46% 8.17% 15.76% 0.00% -10.08% -9.57% -31.01%
Free Cash Flow Firm Q/Q Growth
-23.47% 3.56% 51.14% -2.98% 307.80% -78.64% -182.05% -85.89% 111.85% -22.88% -88.00%
Invested Capital Q/Q Growth
3.66% -0.05% 6.39% -2.87% -10.35% -1.69% 27.20% 0.00% -6.12% -1.55% -4.53%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
26.55% 19.37% 21.90% 23.01% 15.52% 13.63% 29.67% 25.79% 17.68% 16.12% 7.28%
EBITDA Margin
27.87% 20.00% 22.90% 24.33% 17.33% 16.60% 31.36% 26.46% 15.64% 18.21% -2.22%
Operating Margin
21.51% 11.49% 15.23% 16.31% 8.08% 5.72% 23.77% 19.31% 5.81% 7.21% -14.13%
EBIT Margin
22.36% 12.55% 15.42% 16.91% 8.55% 6.30% 24.22% 19.77% 6.89% 9.03% -12.77%
Profit (Net Income) Margin
14.90% 8.27% 16.65% 11.97% 5.69% 4.97% 17.58% 14.54% 4.16% 5.33% -13.17%
Tax Burden Percent
69.06% 75.27% 123.87% 77.51% 81.05% 112.69% 77.33% 77.97% 74.57% 68.98% 92.11%
Interest Burden Percent
96.49% 87.60% 87.18% 91.37% 82.13% 69.98% 93.83% 94.33% 80.92% 85.51% 111.99%
Effective Tax Rate
30.95% 24.73% -23.87% 22.49% 18.95% -12.69% 22.67% 22.03% 25.43% 31.02% 0.00%
Return on Invested Capital (ROIC)
21.52% 8.57% 20.54% 14.16% 6.99% 6.34% 23.32% 20.89% 4.68% 5.28% -9.82%
ROIC Less NNEP Spread (ROIC-NNEP)
20.83% 7.22% 14.07% 11.27% 1.91% -3.37% 17.83% 16.59% 2.51% 13.57% -43.81%
Return on Net Nonoperating Assets (RNNOA)
-1.86% 2.70% 8.38% 3.91% 0.42% -0.59% 4.08% 3.30% 0.24% 0.65% -4.64%
Return on Equity (ROE)
19.66% 11.27% 28.92% 18.07% 7.40% 5.75% 27.41% 24.19% 4.92% 5.93% -14.47%
Cash Return on Invested Capital (CROIC)
17.84% -68.84% 12.76% 13.34% 10.31% 2.58% -9.22% 10.52% 10.91% 2.18% -3.46%
Operating Return on Assets (OROA)
18.51% 7.74% 10.80% 12.33% 5.58% 3.49% 17.67% 16.01% 4.16% 5.25% -7.01%
Return on Assets (ROA)
12.33% 5.10% 11.66% 8.73% 3.72% 2.75% 12.82% 11.78% 2.51% 3.10% -7.23%
Return on Common Equity (ROCE)
17.96% 10.27% 26.22% 16.52% 6.79% 5.27% 25.40% 22.78% 4.67% 5.65% -13.74%
Return on Equity Simple (ROE_SIMPLE)
20.36% 11.92% 27.47% 18.50% 7.88% 6.17% 26.02% 23.13% 5.10% 6.15% 0.00%
Net Operating Profit after Tax (NOPAT)
663 439 1,517 1,091 532 483 2,165 2,378 544 604 -1,105
NOPAT Margin
14.85% 8.64% 18.87% 12.64% 6.55% 6.44% 18.38% 15.06% 4.33% 4.97% -9.89%
Net Nonoperating Expense Percent (NNEP)
0.69% 1.35% 6.47% 2.89% 5.08% 9.70% 5.50% 4.30% 2.17% -8.29% 33.99%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 15.50% 3.47% 3.87% -7.42%
Cost of Revenue to Revenue
73.45% 80.63% 78.10% 76.99% 84.48% 86.37% 70.33% 74.21% 82.32% 83.88% 92.72%
SG&A Expenses to Revenue
4.88% 5.08% 4.96% 5.15% 5.64% 5.98% 4.68% 5.29% 6.89% 7.20% 8.06%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.04% 7.88% 6.67% 6.71% 7.44% 7.92% 5.90% 6.48% 11.87% 8.91% 21.41%
Earnings before Interest and Taxes (EBIT)
998 637 1,240 1,460 694 473 2,853 3,123 865 1,097 -1,426
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,244 1,015 1,841 2,101 1,407 1,246 3,693 4,179 1,962 2,211 -248
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.93 1.85 2.57 1.41 1.44 1.64 1.51 1.28 1.73 1.40 1.08
Price to Tangible Book Value (P/TBV)
2.06 3.63 4.06 1.77 1.83 2.28 2.75 2.06 2.60 2.05 1.51
Price to Revenue (P/Rev)
1.41 1.28 1.56 0.91 1.04 1.32 1.02 0.81 1.41 1.22 0.85
Price to Earnings (P/E)
9.75 16.30 9.61 7.90 20.00 30.09 5.94 5.68 36.91 24.51 0.00
Dividend Yield
1.44% 1.47% 0.83% 1.51% 1.56% 1.37% 1.21% 1.31% 1.24% 1.79% 2.85%
Earnings Yield
10.26% 6.13% 10.40% 12.66% 5.00% 3.32% 16.82% 17.61% 2.71% 4.08% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.97 1.42 2.00 1.29 1.41 1.50 1.37 1.24 1.66 1.36 1.06
Enterprise Value to Revenue (EV/Rev)
1.38 1.99 1.91 1.16 1.30 1.55 1.26 0.94 1.49 1.30 1.04
Enterprise Value to EBITDA (EV/EBITDA)
4.96 9.93 8.33 4.77 7.51 9.36 4.01 3.54 9.53 7.16 0.00
Enterprise Value to EBIT (EV/EBIT)
6.18 15.83 12.37 6.86 15.23 24.65 5.19 4.74 21.61 14.43 0.00
Enterprise Value to NOPAT (EV/NOPAT)
9.30 22.97 10.11 9.18 19.87 24.12 6.84 6.22 34.38 26.24 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
5.72 11.63 10.04 7.11 8.12 8.99 6.19 4.36 8.00 12.05 24.91
Enterprise Value to Free Cash Flow (EV/FCFF)
11.22 0.00 16.27 9.74 13.47 59.35 0.00 12.36 14.75 63.45 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.21 0.98 0.71 0.44 0.54 0.54 0.61 0.47 0.46 0.41 0.60
Long-Term Debt to Equity
0.21 0.95 0.58 0.44 0.54 0.54 0.58 0.47 0.43 0.41 0.55
Financial Leverage
-0.09 0.37 0.60 0.35 0.22 0.18 0.23 0.20 0.09 0.05 0.11
Leverage Ratio
1.59 2.21 2.48 2.07 1.99 2.09 2.14 2.05 1.96 1.92 2.00
Compound Leverage Factor
1.54 1.93 2.16 1.89 1.64 1.46 2.01 1.94 1.59 1.64 2.24
Debt to Total Capital
17.55% 49.59% 41.68% 30.51% 34.98% 35.15% 37.79% 31.80% 31.31% 29.23% 37.53%
Short-Term Debt to Total Capital
0.00% 1.93% 7.71% 0.00% 0.00% 0.00% 1.96% 0.00% 1.91% 0.04% 3.34%
Long-Term Debt to Total Capital
17.55% 47.66% 33.97% 30.51% 34.98% 35.15% 35.83% 31.80% 29.40% 29.20% 34.19%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
6.85% 4.77% 5.38% 5.56% 5.51% 5.27% 4.18% 3.48% 3.34% 3.31% 3.38%
Common Equity to Total Capital
75.60% 45.65% 52.94% 63.93% 59.50% 59.57% 58.03% 64.72% 65.35% 67.46% 59.09%
Debt to EBITDA
0.61 3.77 2.08 1.27 2.45 2.86 1.40 1.17 2.50 2.06 -22.52
Net Debt to EBITDA
-0.34 3.16 1.25 0.79 1.14 0.96 0.61 0.36 0.25 0.25 -6.43
Long-Term Debt to EBITDA
0.61 3.62 1.70 1.27 2.45 2.86 1.33 1.17 2.35 2.06 -20.51
Debt to NOPAT
1.14 8.72 2.53 2.44 6.48 7.38 2.39 2.05 9.02 7.56 -5.06
Net Debt to NOPAT
-0.64 7.31 1.52 1.52 3.02 2.47 1.05 0.63 0.90 0.93 -1.44
Long-Term Debt to NOPAT
1.14 8.38 2.06 2.44 6.48 7.38 2.27 2.05 8.47 7.55 -4.61
Altman Z-Score
4.41 1.79 2.81 2.85 2.27 2.26 2.65 2.92 2.66 2.61 1.67
Noncontrolling Interest Sharing Ratio
8.67% 8.91% 9.32% 8.57% 8.25% 8.30% 7.33% 5.83% 4.98% 4.76% 5.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.16 2.04 1.76 2.40 2.21 2.56 2.25 2.60 2.37 2.80 2.24
Quick Ratio
3.24 1.18 1.29 1.51 1.42 1.86 1.61 1.75 1.76 1.98 1.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
549 -3,524 942 1,028 785 196 -856 1,197 1,267 250 -389
Operating Cash Flow to CapEx
219.76% 137.84% 264.82% 200.71% 165.31% 247.05% 363.83% 306.41% 225.92% 130.36% 46.73%
Free Cash Flow to Firm to Interest Expense
15.70 -44.60 5.93 8.16 6.33 1.38 -4.86 6.76 7.68 1.57 -2.27
Operating Cash Flow to Interest Expense
30.83 10.97 9.61 11.18 10.49 9.13 13.60 19.18 14.16 8.26 2.72
Operating Cash Flow Less CapEx to Interest Expense
16.80 3.01 5.98 5.61 4.15 5.44 9.86 12.92 7.89 1.92 -3.10
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.83 0.62 0.70 0.73 0.65 0.55 0.73 0.81 0.60 0.58 0.55
Accounts Receivable Turnover
8.35 7.01 8.29 8.47 7.83 6.67 7.64 8.61 7.38 7.87 7.48
Inventory Turnover
6.83 6.63 7.38 6.95 7.03 6.99 7.13 7.16 5.92 6.14 6.18
Fixed Asset Turnover
1.55 1.08 1.25 1.33 1.20 1.09 1.62 1.96 1.48 1.42 1.30
Accounts Payable Turnover
13.21 11.19 11.46 12.01 14.00 12.85 11.71 13.26 11.70 11.79 12.68
Days Sales Outstanding (DSO)
43.72 52.04 44.03 43.07 46.60 54.72 47.76 42.40 49.48 46.35 48.80
Days Inventory Outstanding (DIO)
53.44 55.07 49.43 52.54 51.89 52.21 51.23 50.96 61.63 59.47 59.03
Days Payable Outstanding (DPO)
27.64 32.61 31.85 30.39 26.08 28.41 31.18 27.53 31.20 30.96 28.79
Cash Conversion Cycle (CCC)
69.52 74.50 61.61 65.23 72.42 78.52 67.81 65.83 79.90 74.86 79.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,137 7,100 7,675 7,738 7,485 7,772 10,793 11,974 11,251 11,605 10,889
Invested Capital Turnover
1.45 0.99 1.09 1.12 1.07 0.98 1.27 1.39 1.08 1.06 0.99
Increase / (Decrease) in Invested Capital
113 3,963 575 63 -253 287 3,021 1,181 -723 354 -716
Enterprise Value (EV)
6,168 10,081 15,335 10,014 10,567 11,659 14,817 14,800 18,688 15,834 11,582
Market Capitalization
6,297 6,505 12,534 7,866 8,419 9,930 11,979 12,757 17,678 14,756 9,485
Book Value per Share
$25.00 $27.34 $37.75 $43.28 $45.66 $47.31 $62.24 $77.60 $79.92 $81.79 $68.54
Tangible Book Value per Share
$23.36 $13.89 $23.89 $34.48 $35.83 $34.04 $34.04 $48.49 $53.04 $56.05 $49.08
Total Capital
4,320 7,720 9,206 8,744 9,848 10,144 13,708 15,344 15,670 15,605 14,879
Total Debt
758 3,828 3,837 2,668 3,445 3,566 5,180 4,879 4,906 4,562 5,584
Total Long-Term Debt
758 3,679 3,127 2,668 3,445 3,566 4,911 4,879 4,607 4,556 5,087
Net Debt
-425 3,208 2,306 1,662 1,605 1,194 2,265 1,509 487 562 1,594
Capital Expenditures (CapEx)
491 629 577 702 787 525 658 1,108 1,034 1,008 995
Debt-free, Cash-free Net Working Capital (DFCFNWC)
470 754 675 906 773 807 1,280 1,447 814 1,082 1,015
Debt-free Net Working Capital (DFNWC)
1,653 1,374 2,206 1,659 1,501 2,120 3,188 3,675 4,118 4,001 3,943
Net Working Capital (NWC)
1,653 1,225 1,496 1,659 1,501 2,120 2,919 3,675 3,819 3,995 3,446
Net Nonoperating Expense (NNE)
-2.07 19 178 57 70 110 95 81 22 -43 366
Net Nonoperating Obligations (NNO)
-425 3,208 2,306 1,662 1,082 1,194 2,265 1,509 487 562 1,594
Total Depreciation and Amortization (D&A)
246 378 601 641 713 773 840 1,056 1,097 1,114 1,178
Debt-free, Cash-free Net Working Capital to Revenue
10.53% 14.85% 8.39% 10.49% 9.52% 10.75% 10.87% 9.16% 6.49% 8.91% 9.09%
Debt-free Net Working Capital to Revenue
37.03% 27.07% 27.43% 19.21% 18.49% 28.25% 27.07% 23.27% 32.82% 32.95% 35.30%
Net Working Capital to Revenue
37.03% 24.13% 18.60% 19.21% 18.49% 28.25% 24.78% 23.27% 30.44% 32.90% 30.85%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.88 $3.07 $10.05 $7.66 $3.26 $2.57 $15.66 $17.46 $3.73 $4.66 ($11.70)
Adjusted Weighted Average Basic Shares Outstanding
131.82M 129.37M 129.09M 129.40M 128.40M 127.85M 128.00M 127.97M 127.81M 128.54M 128.26M
Adjusted Diluted Earnings per Share
$4.86 $3.06 $10.00 $7.62 $3.25 $2.56 $15.58 $17.34 $3.70 $4.64 ($11.70)
Adjusted Weighted Average Diluted Shares Outstanding
132.30M 129.97M 129.54M 129.99M 128.76M 128.09M 128.70M 128.85M 128.60M 129.21M 128.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
130.22M 128.93M 129.42M 128.47M 128.39M 127.83M 127.92M 127.36M 128.22M 128.23M 127.91M
Normalized Net Operating Profit after Tax (NOPAT)
663 517 878 1,117 562 326 2,181 2,404 919 666 -148
Normalized NOPAT Margin
14.85% 10.19% 10.92% 12.94% 6.92% 4.34% 18.52% 15.22% 7.32% 5.49% -1.32%
Pre Tax Income Margin
21.58% 10.99% 13.44% 15.45% 7.02% 4.41% 22.73% 18.65% 5.58% 7.73% -14.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
28.51 8.06 7.80 11.59 5.60 3.33 16.21 17.64 5.24 6.90 -8.34
NOPAT to Interest Expense
18.94 5.55 9.54 8.66 4.29 3.40 12.30 13.44 3.29 3.80 -6.46
EBIT Less CapEx to Interest Expense
14.49 0.10 4.17 6.02 -0.75 -0.37 12.47 11.38 -1.02 0.56 -14.16
NOPAT Less CapEx to Interest Expense
4.91 -2.41 5.91 3.09 -2.06 -0.29 8.56 7.18 -2.97 -2.54 -12.28
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
16.09% 27.14% 9.78% 15.96% 39.39% 51.47% 9.32% 9.97% 52.68% 48.38% -21.96%
Augmented Payout Ratio
40.60% 43.10% 9.78% 26.21% 45.89% 65.95% 10.77% 14.37% 57.09% 57.65% -26.24%

Quarterly Metrics And Ratios for Westlake

This table displays calculated financial ratios and metrics derived from Westlake's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 127,910,338.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 127,910,338.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -1.32
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.26% -14.34% -11.35% -1.35% 0.06% 0.60% -4.34% -7.92% -8.95% -10.90% -6.82%
EBITDA Growth
-15.17% -137.96% -33.82% 7.83% -25.95% 277.02% -47.25% -71.77% -185.35% -175.72% -47.92%
EBIT Growth
-25.00% -248.56% -51.08% 10.98% -44.69% 126.11% -98.17% -118.28% -427.68% -553.33% -2,780.00%
NOPAT Growth
-34.19% -245.32% -58.12% -4.09% -58.61% 103.38% -112.65% -124.67% -559.25% -3,695.79% -437.50%
Net Income Growth
-28.40% -296.37% -54.55% 5.21% -59.32% 103.90% -118.92% -140.56% -743.33% -2,905.26% -348.57%
EPS Growth
-29.03% -313.26% -56.07% 3.90% -62.27% 101.81% -123.13% -146.25% -830.12% -6,128.57% -322.58%
Operating Cash Flow Growth
-26.50% -31.38% -66.99% -57.30% -31.90% -24.26% -145.56% -43.04% -61.60% -48.16% -22.08%
Free Cash Flow Firm Growth
-231.28% 136.78% 62.34% 19.00% 102.67% -201.29% -154.25% -150.42% -149.30% 172.24% 265.60%
Invested Capital Growth
0.00% -6.04% -5.29% -2.65% -1.64% 3.15% 3.67% 2.04% -3.24% -6.17% -7.18%
Revenue Q/Q Growth
-4.18% -9.28% 5.27% 7.80% -2.81% -8.79% 0.11% 3.76% -3.89% -10.75% 4.70%
EBITDA Q/Q Growth
-1.16% -134.46% 332.34% 36.26% -32.12% -17.62% -30.77% -27.08% -305.24% 26.91% 147.62%
EBIT Q/Q Growth
-3.34% -227.65% 152.80% 70.33% -51.83% -39.73% -96.30% -1,800.00% -763.53% 16.62% 78.10%
NOPAT Q/Q Growth
-12.53% -236.99% 145.82% 74.68% -62.25% -88.81% -271.48% -240.63% -602.75% 12.40% 74.37%
Net Income Q/Q Growth
-3.91% -265.08% 137.99% 74.59% -62.85% -84.17% -284.21% -274.29% -489.31% 30.96% 70.54%
EPS Q/Q Growth
-4.76% -275.45% 134.72% 79.10% -65.42% -91.57% -542.86% -258.06% -445.95% 30.36% 68.96%
Operating Cash Flow Q/Q Growth
25.41% -17.67% -70.51% 40.24% 100.00% -8.44% -117.74% 275.32% 34.81% 23.63% -141.78%
Free Cash Flow Firm Q/Q Growth
-2,305.95% 102.88% 143.93% -23.11% -50.46% -209.01% -30.64% 28.54% 51.56% 259.73% 199.47%
Invested Capital Q/Q Growth
-1.56% -6.12% 2.49% 2.78% -0.54% -1.55% 3.01% 1.17% -5.69% -4.53% 1.90%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
18.81% 7.04% 15.66% 20.70% 16.01% 11.54% 8.15% 8.74% 8.32% 3.43% 4.22%
EBITDA Margin
21.89% -8.32% 18.35% 23.20% 16.20% 14.63% 10.12% 7.11% -15.19% -12.44% 5.66%
Operating Margin
11.20% -19.53% 7.50% 12.66% 5.77% 2.32% -1.12% -3.69% -26.99% -26.49% -6.49%
EBIT Margin
13.00% -18.29% 9.18% 14.50% 7.19% 4.75% 0.18% -2.88% -25.86% -24.16% -5.05%
Profit (Net Income) Margin
9.47% -17.23% 6.22% 10.07% 3.85% 0.67% -1.23% -4.44% -27.20% -21.04% -5.92%
Tax Burden Percent
80.82% 87.28% 79.40% 76.18% 64.86% 19.79% 102.94% 104.80% 99.61% 80.39% 82.63%
Interest Burden Percent
90.12% 107.93% 85.35% 91.18% 82.59% 71.11% -680.00% 147.06% 105.59% 108.33% 141.79%
Effective Tax Rate
19.18% 0.00% 20.60% 23.82% 35.14% 80.21% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
19.68% -14.77% 6.11% 9.73% 3.82% 0.49% -0.81% -2.54% -18.70% -18.42% -4.32%
ROIC Less NNEP Spread (ROIC-NNEP)
23.38% -24.85% 6.89% 11.21% 4.32% 1.62% -2.28% -7.85% -41.49% -24.29% -6.70%
Return on Net Nonoperating Assets (RNNOA)
1.45% -2.34% 0.64% 0.94% 0.25% 0.08% -0.18% -0.74% -4.07% -2.57% -1.03%
Return on Equity (ROE)
21.13% -17.11% 6.75% 10.67% 4.07% 0.57% -0.98% -3.28% -22.77% -20.99% -5.36%
Cash Return on Invested Capital (CROIC)
-178.42% 10.91% 7.96% 5.10% 2.72% 2.18% -0.24% -2.22% -1.78% -3.46% -2.99%
Operating Return on Assets (OROA)
15.82% -11.04% 5.35% 8.36% 4.10% 2.76% 0.10% -1.62% -14.51% -13.26% -2.74%
Return on Assets (ROA)
11.53% -10.40% 3.62% 5.81% 2.20% 0.39% -0.71% -2.49% -15.26% -11.55% -3.22%
Return on Common Equity (ROCE)
20.13% -16.26% 6.42% 10.16% 3.88% 0.54% -0.94% -3.12% -21.65% -19.94% -5.08%
Return on Equity Simple (ROE_SIMPLE)
11.69% 0.00% 2.90% 2.99% 1.32% 0.00% 4.10% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
282 -386 177 309 117 13 -22 -76 -536 -470 -120
NOPAT Margin
9.06% -13.67% 5.95% 9.64% 3.75% 0.46% -0.79% -2.58% -18.89% -18.54% -4.54%
Net Nonoperating Expense Percent (NNEP)
-3.70% 10.08% -0.78% -1.48% -0.50% -1.13% 1.47% 5.31% 22.78% 5.87% 2.38%
Return On Investment Capital (ROIC_SIMPLE)
- -2.47% - - - 0.08% -0.14% -0.49% -3.67% -3.16% -0.82%
Cost of Revenue to Revenue
81.19% 92.96% 84.34% 79.30% 83.99% 88.46% 91.85% 91.26% 91.68% 96.57% 95.78%
SG&A Expenses to Revenue
6.61% 7.93% 7.03% 6.98% 6.90% 7.95% 7.98% 7.48% 8.03% 8.84% 8.90%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
7.61% 26.57% 8.17% 8.04% 10.23% 9.22% 9.28% 12.43% 35.31% 29.93% 10.71%
Earnings before Interest and Taxes (EBIT)
405 -517 273 465 224 135 5.00 -85 -734 -612 -134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
682 -235 546 744 505 416 288 210 -431 -315 150
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.46 1.73 1.88 1.75 1.81 1.40 1.23 0.95 1.05 1.08 1.75
Price to Tangible Book Value (P/TBV)
2.20 2.60 2.81 2.58 2.64 2.05 1.80 1.39 1.43 1.51 2.50
Price to Revenue (P/Rev)
1.21 1.41 1.60 1.53 1.59 1.22 1.07 0.83 0.86 0.85 1.36
Price to Earnings (P/E)
12.99 36.91 75.09 67.47 197.20 24.51 33.06 0.00 0.00 0.00 0.00
Dividend Yield
1.28% 1.24% 1.22% 1.39% 1.35% 1.79% 2.07% 2.77% 2.73% 2.85% 1.81%
Earnings Yield
7.70% 2.71% 1.33% 1.48% 0.51% 4.08% 3.02% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.41 1.66 1.79 1.67 1.73 1.36 1.20 0.96 1.04 1.06 1.58
Enterprise Value to Revenue (EV/Rev)
1.30 1.49 1.70 1.64 1.69 1.30 1.20 0.98 1.03 1.04 1.59
Enterprise Value to EBITDA (EV/EBITDA)
6.01 9.53 12.27 11.42 13.11 7.16 7.36 8.14 24.56 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
9.78 21.61 35.60 31.68 45.96 14.43 17.34 41.41 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
13.09 34.38 68.99 68.35 160.28 26.24 36.42 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
6.51 8.00 10.36 11.84 14.08 12.05 13.46 11.96 17.60 24.91 39.04
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 14.75 21.89 32.40 63.20 63.45 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.43 0.46 0.45 0.44 0.41 0.41 0.42 0.43 0.47 0.60 0.62
Long-Term Debt to Equity
0.41 0.43 0.42 0.41 0.41 0.41 0.42 0.43 0.39 0.55 0.56
Financial Leverage
0.06 0.09 0.09 0.08 0.06 0.05 0.08 0.09 0.10 0.11 0.15
Leverage Ratio
1.90 1.96 1.93 1.90 1.89 1.92 1.91 1.91 1.94 2.00 2.02
Compound Leverage Factor
1.71 2.11 1.64 1.73 1.56 1.36 -13.01 2.81 2.05 2.17 2.87
Debt to Total Capital
30.16% 31.31% 31.06% 30.57% 29.21% 29.23% 29.58% 30.13% 31.90% 37.53% 38.10%
Short-Term Debt to Total Capital
1.85% 1.91% 1.91% 1.88% 0.00% 0.04% 0.00% 0.00% 5.14% 3.34% 3.39%
Long-Term Debt to Total Capital
28.31% 29.40% 29.16% 28.69% 29.21% 29.20% 29.58% 30.13% 26.76% 34.19% 34.70%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.29% 3.34% 3.32% 3.25% 3.32% 3.31% 3.29% 3.32% 3.51% 3.38% 3.45%
Common Equity to Total Capital
66.56% 65.35% 65.62% 66.17% 67.47% 67.46% 67.12% 66.55% 64.59% 59.09% 58.46%
Debt to EBITDA
1.73 2.50 2.91 2.81 2.96 2.06 2.35 3.28 9.64 -22.52 -14.43
Net Debt to EBITDA
0.25 0.25 0.40 0.44 0.39 0.25 0.53 0.92 3.04 -6.43 -5.30
Long-Term Debt to EBITDA
1.62 2.35 2.73 2.64 2.96 2.06 2.35 3.28 8.09 -20.51 -13.15
Debt to NOPAT
3.77 9.02 16.34 16.84 36.18 7.56 11.63 -200.28 -7.91 -5.06 -4.63
Net Debt to NOPAT
0.54 0.90 2.27 2.61 4.72 0.93 2.62 -56.07 -2.49 -1.44 -1.70
Long-Term Debt to NOPAT
3.54 8.47 15.34 15.80 36.18 7.55 11.63 -200.28 -6.64 -4.61 -4.22
Altman Z-Score
2.53 2.44 2.68 2.69 2.72 2.46 2.28 2.02 1.89 1.81 2.17
Noncontrolling Interest Sharing Ratio
4.71% 4.98% 4.88% 4.75% 4.69% 4.76% 4.74% 4.72% 4.90% 5.01% 5.08%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.54 2.37 2.46 2.61 2.79 2.80 2.64 2.47 1.99 2.24 2.17
Quick Ratio
1.88 1.76 1.81 1.91 1.99 1.98 1.81 1.71 1.34 1.60 1.52
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-11,702 337 821 631 313 -341 -445 -318 -154 246 738
Operating Cash Flow to CapEx
284.08% 203.19% 62.13% 102.60% 215.45% 152.28% -31.05% 50.56% 76.15% 93.36% -44.98%
Free Cash Flow to Firm to Interest Expense
-292.55 8.21 20.53 15.40 8.02 -8.74 -11.42 -7.96 -3.76 4.83 13.17
Operating Cash Flow to Interest Expense
17.40 13.98 4.23 5.78 12.15 11.13 -1.97 3.38 4.44 4.41 -1.68
Operating Cash Flow Less CapEx to Interest Expense
11.28 7.10 -2.58 0.15 6.51 3.82 -8.33 -3.30 -1.39 -0.31 -5.41
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.22 0.60 0.58 0.58 0.57 0.58 0.58 0.56 0.56 0.55 0.54
Accounts Receivable Turnover
0.00 7.38 6.90 6.61 6.57 7.87 7.18 6.45 6.53 7.48 6.56
Inventory Turnover
0.00 5.92 5.87 6.09 6.02 6.14 5.98 6.12 6.00 6.18 5.95
Fixed Asset Turnover
0.00 1.48 1.43 1.42 1.41 1.42 1.40 1.35 1.32 1.30 1.27
Accounts Payable Turnover
0.00 11.70 11.95 12.10 12.05 11.79 11.15 11.53 12.29 12.68 11.65
Days Sales Outstanding (DSO)
0.00 49.48 52.89 55.20 55.59 46.35 50.85 56.56 55.91 48.80 55.63
Days Inventory Outstanding (DIO)
0.00 61.63 62.22 59.98 60.60 59.47 61.05 59.69 60.81 59.03 61.37
Days Payable Outstanding (DPO)
0.00 31.20 30.54 30.16 30.29 30.96 32.74 31.65 29.70 28.79 31.34
Cash Conversion Cycle (CCC)
0.00 79.90 84.58 85.02 85.89 74.86 79.15 84.59 87.02 79.04 85.66
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,984 11,251 11,531 11,852 11,788 11,605 11,954 12,094 11,406 10,889 11,096
Invested Capital Turnover
2.17 1.08 1.03 1.01 1.02 1.06 1.02 0.98 0.99 0.99 0.95
Increase / (Decrease) in Invested Capital
11,984 -723 -644 -322 -196 354 423 242 -382 -716 -858
Enterprise Value (EV)
16,924 18,688 20,648 19,831 20,451 15,834 14,371 11,553 11,863 11,582 17,491
Market Capitalization
15,694 17,678 19,448 18,553 19,325 14,756 12,827 9,737 9,883 9,485 14,942
Book Value per Share
$84.22 $79.92 $80.48 $82.24 $82.92 $81.79 $81.18 $80.15 $73.50 $68.54 $66.82
Tangible Book Value per Share
$55.78 $53.04 $53.94 $56.01 $56.86 $56.05 $55.52 $54.55 $53.83 $49.08 $46.81
Total Capital
16,158 15,670 15,743 15,979 15,802 15,605 15,509 15,445 14,594 14,879 14,621
Total Debt
4,873 4,906 4,890 4,885 4,616 4,562 4,588 4,654 4,656 5,584 5,570
Total Long-Term Debt
4,574 4,607 4,590 4,585 4,616 4,556 4,588 4,654 3,906 5,087 5,074
Net Debt
699 487 678 758 602 562 1,033 1,303 1,468 1,594 2,045
Capital Expenditures (CapEx)
245 282 272 231 220 285 248 267 239 241 209
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,340 814 1,063 1,330 1,283 1,082 1,256 1,266 1,479 1,015 1,229
Debt-free Net Working Capital (DFNWC)
4,397 4,118 4,171 4,372 4,198 4,001 3,736 3,543 3,604 3,943 3,705
Net Working Capital (NWC)
4,098 3,819 3,871 4,072 4,198 3,995 3,736 3,543 2,854 3,446 3,209
Net Nonoperating Expense (NNE)
-13 101 -7.94 -14 -3.24 -5.94 13 55 236 63 37
Net Nonoperating Obligations (NNO)
699 487 678 758 602 562 1,033 1,303 1,468 1,594 2,045
Total Depreciation and Amortization (D&A)
277 282 273 279 281 281 283 295 303 297 284
Debt-free, Cash-free Net Working Capital to Revenue
10.29% 6.49% 8.74% 10.97% 10.58% 8.91% 10.46% 10.77% 12.88% 9.09% 11.20%
Debt-free Net Working Capital to Revenue
33.77% 32.82% 34.28% 36.06% 34.62% 32.95% 31.10% 30.13% 31.39% 35.30% 33.76%
Net Working Capital to Revenue
31.47% 30.44% 31.82% 33.59% 34.62% 32.90% 31.10% 30.13% 24.86% 30.85% 29.24%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.22 ($3.88) $1.35 $2.42 $0.84 $0.05 ($0.31) ($1.11) ($6.06) ($4.22) ($1.31)
Adjusted Weighted Average Basic Shares Outstanding
127.85M 127.81M 128.36M 128.58M 128.64M 128.54M 128.31M 128.24M 128.25M 128.26M 127.99M
Adjusted Diluted Earnings per Share
$2.20 ($3.86) $1.34 $2.40 $0.83 $0.07 ($0.31) ($1.11) ($6.06) ($4.22) ($1.31)
Adjusted Weighted Average Diluted Shares Outstanding
128.58M 128.60M 129.02M 129.35M 129.34M 129.21M 128.31M 128.24M 128.25M 128.26M 127.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
128.14M 128.22M 128.57M 128.59M 128.71M 128.23M 128.24M 128.25M 128.27M 127.91M 128.12M
Normalized Net Operating Profit after Tax (NOPAT)
282 -371 180 312 165 52 -18 4.20 -15 -119 -108
Normalized NOPAT Margin
9.06% -13.13% 6.06% 9.74% 5.31% 1.82% -0.61% 0.14% -0.54% -4.70% -4.06%
Pre Tax Income Margin
11.72% -19.75% 7.83% 13.22% 5.94% 3.38% -1.19% -4.23% -27.31% -26.17% -7.16%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.13 -12.61 6.83 11.34 5.74 3.46 0.13 -2.13 -17.90 -12.00 -2.39
NOPAT to Interest Expense
7.05 -9.42 4.43 7.54 2.99 0.33 -0.57 -1.91 -13.08 -9.21 -2.15
EBIT Less CapEx to Interest Expense
4.00 -19.49 0.03 5.71 0.10 -3.85 -6.23 -8.80 -23.73 -16.73 -6.13
NOPAT Less CapEx to Interest Expense
0.93 -16.30 -2.37 1.91 -2.65 -6.97 -6.93 -8.58 -18.91 -13.94 -5.88
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.76% 52.68% 97.67% 98.10% 222.70% 48.38% 74.00% -1,188.89% -35.04% -21.96% -20.28%
Augmented Payout Ratio
25.22% 57.09% 98.00% 98.10% 222.70% 57.65% 95.08% -1,522.22% -44.83% -26.24% -22.35%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Westlake’s quarterly statements over the last four years (2022–2025), focused on cash flow, profitability and leverage. Items are shown with positives first, then neutral, then negatives.

  • Operating cash flow remained positive across the period, with 2024 quarters showing solid cash generation (for example, net cash from continuing operating activities: 2024 Q4 about $434M; 2024 Q3 about $474M), and 2025 quarters continuing to show positive operating cash flow (2025 Q4: $225M; 2025 Q3: $182M; 2025 Q2: $135M).
  • The company maintained a relatively steady per-share dividend around $0.53 (cash dividends per share in 2025 Q3 were $0.53, with 2025 Q2 at roughly $0.525). This suggests continued shareholder returns despite earnings volatility.
  • Liquidity remained solid, with cash & equivalents generally around $2B and peaking above $3B in 2024 (for example, 2024 Q2 cash & equivalents: $3.042B; 2025 Q1–Q4 cash levels near $1.9–2.3B across quarters).
  • The equity base stayed sizable, with total common equity around $9.4B and total equity (including noncontrolling interests) near $9.9–10.3B across the window (2024 Q4 total common equity about $10.278B; 2025 Q3 around $9.426B; total equity roughly $9.9B in recent quarters).
  • Revenue generally trended in the $2.5B–$3.3B range each year, with 2025 quarterly revenue (e.g., 2025 Q4: $2.533B; 2025 Q3: $2.839B; 2025 Q2: $2.953B) lower on average than the 2022–2023 peak levels, indicating a gradual downshift in top-line performance.
  • 2025 includes several large, non-recurring charges (impairment of $727M in 2025 Q3 and restructuring charges of $501M in 2025 Q4), which materially weighed on operating income and net income but are not indicative of ongoing recurring expenses.
  • Debt remained substantial, with long-term debt generally in the mid-to-high billions (roughly $4.5B–$4.6B in 2024–2025, varying by quarter), indicating a high leverage footprint that warrants close monitoring.
  • Net income attributable to common shareholders deteriorated in 2025, turning negative across the quarters (2025 Q1: -$35M; Q2: -$131M; Q3: -$782M; Q4: -$544M), signaling a profitability challenge even as cash flow remained positive.
  • Earnings per share reflected the earnings weakness in 2025 (Q1 2025 EPS -$0.31; Q2 -$1.11; Q3 -$6.06; Q4 -$4.22), highlighting the impact of the year’s losses on shareholder returns.
  • Investing cash outflows were repeatedly substantial, contributing to negative free cash flow in several periods (for example, 2025 Q4 net cash from investing activities around -$255M; 2025 Q3 around -$242M; 2025 Q2 around -$292M; 2025 Q1 around -$434M), reflecting ongoing capital expenditures and investments.
05/11/26 12:46 PM ETAI Generated. May Contain Errors.

Westlake Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Westlake's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Westlake's net income appears to be on a downward trend, with a most recent value of -$1.47 billion in 2025, falling from $665 million in 2015. The previous period was $647 million in 2024. See Westlake's forecast for analyst expectations on what's next for the company.

Westlake's total operating income in 2025 was -$1.58 billion, based on the following breakdown:
  • Total Gross Profit: $813 million
  • Total Operating Expenses: $2.39 billion

Over the last 10 years, Westlake's total revenue changed from $4.46 billion in 2015 to $11.17 billion in 2025, a change of 150.3%.

Westlake's total liabilities were at $10.67 billion at the end of 2025, a 9.9% increase from 2024, and a 431.3% increase since 2015.

In the past 10 years, Westlake's cash and equivalents has ranged from $459 million in 2016 to $3.30 billion in 2023, and is currently $2.72 billion as of their latest financial filing in 2025.

Over the last 10 years, Westlake's book value per share changed from 25.00 in 2015 to 68.54 in 2025, a change of 174.2%.



Financial statements for NYSE:WLK last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners